Skip to main content
Registrieren
Springer Medizin Österreich
SUCHE
MENÜ 1 2 3 4
main-content
nach oben

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 21-22/2021

04.10.2021 | case report

New insights and antimicrobial stewardship opportunities in viral pneumonia: five lung ultrasound cases

verfasst von: Lukas Antonitsch, Ronald Gallob, Gerhard Weidinger, Joachim Kettenbach

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Antimicrobial stewardship is crucial to avoid antimicrobial resistance in microbes and adverse drug effects in patients. In respiratory infections, however, viral pneumonia is difficult to distinguish from bacterial pneumonia, which explains the overuse of antibiotic therapy in this indication.

Cases

Five cases of lung consolidation are presented. Lung ultrasound, in conjunction with procalcitonin levels, were used to exclude or corroborate bacterial pneumonia.

Conclusion

Lung ultrasound is easy to learn and perform and is helpful in guiding diagnosis in unclear cases of pneumonia and may also offer new insights into the spectrum of certain virus diseases. The use of lung ultrasound can raise awareness in clinicians of the need for antimicrobial stewardship and may help to avoid the unnecessary use of antibiotics.
Vorheriger Artikel Role of new digital technologies and telemedicine in pulmonary rehabilitation
Nächster Artikel New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Jetzt informieren
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med. 1973;79(4):555–60. PubMed
2.
Price DJE, Sleigh JD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet. 1970;296(7685):1213–5.
3.
Selden R, et al. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med. 1971;74(5):657–64. PubMed
4.
Woerther P‑L, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(suppl_1):S29–S34. PubMedPubMedCentral
5.
Kantele A, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837–46. PubMedPubMedCentral
6.
Cassini A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. PubMedPubMedCentral
7.
8.
European Centre for Disease Prevention and Control. Proposals for EU guidelines on the prudent use of antimicrobials in humans. Stockholm: ECDC; 2017.
9.
Kärki T, et al. Burden of healthcare-associated infections in European acute care hospitals. Wien Medizinische Wochenschrift. 2019;169(1):3–5.
10.
Friedrich AW. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go. Wien Med Wochenschr. 2019;169(1):25–30. PubMedPubMedCentral
11.
Wang Q, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35(10):1679–89. PubMed
12.
Hui C, et al. Previous antibiotic exposure and evolution of antibiotic resistance in mechanically ventilated patients with nosocomial infections. J Crit Care. 2013;28(5):728–34. PubMed
13.
Wu D, Jiachang C, Liu J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J. 2011;104(2):106–10. PubMed
14.
Superti Vargas S, Augusti G, Prehn Zavascki A. Risk factors for and mortality of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections. Rev Inst Med trop S Paulo. 2009;51(4):211–6.
15.
Altunsoy A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci. 2011;8(4):339. PubMedPubMedCentral
16.
17.
18.
19.
Godoy P, et al. Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016. BMC Infect Dis. 2020;20(1):80. PubMedPubMedCentral
20.
21.
Zhao X, et al. Airborne Transmission of Influenza Virus in a Hospital of Qinhuangdao During 2017–2018 Flu Season. Food Environ Virol. 2019;11(4):427–39. PubMed
22.
Blackburn RM, et al. Nosocomial transmission of influenza: a retrospective cross-sectional study using next generation sequencing at a hospital in england (2012–2014). Influenza Other Respi Viruses. 2019;13(6):556–63.
23.
Houlihan CF, et al. Use of whole-genome sequencing in the investigation of a nosocomial influenza virus outbreak. J INFECT DIS. 2018;218(9):1485–9. PubMedPubMedCentral
24.
25.
Heyd R, et al. Retrospective analysis of clinical and virological parameters of influenza cases at four university hospitals in Germany, 2015. Infection. 2017;45(3):349–54. PubMed
26.
Álvarez-Lerma F, et al. Characteristics of patients with hospital-acquired influenza A (H1N1) pdm09 virus admitted to the intensive care unit. J Hosp Infect. 2017;95(2):200–6. PubMed
27.
28.
29.
Loubet P, et al. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol. 2017;91:52–7. PubMedPubMedCentral
30.
Cui X, et al. Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission. J Clin Microbiol. 2015;53(2):746–9. PubMedPubMedCentral
31.
32.
Schuetz P, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evid Based Child Health. 2013;8(4):1297–371. PubMed
33.
Schuetz P, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107. PubMed
34.
35.
Schuetz P, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med (cclm). 2019;57(9):1308–18.
36.
Lee C‑C, et al. Combining procalcitonin and rapid multiplex respiratory virus testing for antibiotic stewardship in older adult patients with severe acute respiratory infection. J Am Med Dir Assoc. 2020;21(1):62–7. PubMed
37.
38.
Creamer AW, Alice EK, Albur M. Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy. Breathe. 2019;15(4):296–304. PubMedPubMedCentral
39.
Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure*: the BLUE protocol. Chest. 2008;134(1):117–25. PubMedPubMedCentral
40.
Tsung JW, Kessler DO, Shah VP. Prospective application of clinician-performed lung ultrasonography during the 2009 H1N1 influenza A pandemic: distinguishing viral from bacterial pneumonia. Crit Ultrasound J. 2012;4(1):1–10.
41.
Berce V, et al. The usefulness of lung ultrasound for the aetiological diagnosis of community-acquired pneumonia in children. Sci Rep. 2019;9(1):1–10.
42.
Arbelot C, et al. Lung ultrasound in emergency and critically ill patientsnumber of supervised exams to reach basic competence. Anesthesiology. 2020;132(4):899–907. PubMed
43.
Buonsenso D, et al. Point-of-care lung ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak. Eur Rev Med Pharmacol Sci. 2020;24:2776–80. PubMed
44.
45.
46.
47.
Jeger V, et al. Is there a role for procalcitonin in differentiating uncomplicated and complicated diverticulitis in order to reduce antibiotic therapy? A prospective diagnostic cohort study. Swiss Med Wkly. 2017;147:w14555. PubMed
48.
Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis. 2017;65(10):1736–44. PubMed
49.
Viasus D, et al. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia. J Antimicrob Chemother. 2017;72(2):547–53. PubMed
50.
Nascimento-Carvalho CM, et al. Respiratory viral infections among children with community-acquired pneumonia and pleural effusion. Scand J Infect Dis. 2013;45(6):478–83. PubMed
51.
52.
Karst SM, Zhu S, Goodfellow IG. The molecular pathology of noroviruses. J Pathol. 2015;235(2):206–16. PubMed
53.
Kweon OJ, et al. Fecal respiratory viruses in acute viral respiratory infection and nasopharyngeal diarrheal viruses in acute viral gastroenteritis: clinical impact of ectopic viruses is questionable. J Microbiol Biotechnol. 2018;28(3):465–72. PubMed
54.
Zhang L, et al. Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection. Microbiome. 2020;8(1):1–12.
55.
de Steenhuijsen Piters WAA, Sanders EAM, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675):20140294. PubMedPubMedCentral
56.
57.
Dickson RP, Erb-Downward JR, Huffnagle GB. Homeostasis and its disruption in the lung microbiome. Am J Physiol Cell Mol Physiol. 2015;309(10):L1047–L55.
58.
59.
Marcos MA, et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther. 2006;11(3):351.
60.
61.
62.
63.
To KKW, Yip CCY, Yuen K‑Y. Rhinovirus–from bench to bedside. J Formos Med Assoc. 2017;116(7):496–504. PubMed
64.
To KKW, et al. Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. Clin Microbiol Infect. 2019;25(12):1539–45. PubMedPubMedCentral
Metadaten
Titel
New insights and antimicrobial stewardship opportunities in viral pneumonia: five lung ultrasound cases
verfasst von
Lukas Antonitsch
Ronald Gallob
Gerhard Weidinger
Joachim Kettenbach
Publikationsdatum
04.10.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01946-4

Weitere Artikel der Ausgabe 21-22/2021

Wiener klinische Wochenschrift 21-22/2021 Zur Ausgabe

perspective

New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy

Clinical-Pathological Conference

Clinical-Pathological Conference Series from the Medical University of Graz

original article

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps

original article

A1B and BB blood group genotypes are risk factors for pulmonary embolism

original article

Association of digoxin therapy with case fatality rate in acute pulmonary embolism

Version: 0.1954.0